Crispr Therapeutics shares tumble after significant earnings miss
HOUSTON—Thomas A. Martin, President of Kinder Morgan , Inc. (NYSE:KMI), recently sold 18,000 shares of the company’s Class P common stock, according to a filing with the Securities and Exchange Commission. The shares were sold at a weighted average price of $27.6956, amounting to a total transaction value of $498,520. The transaction comes as the $59.5 billion energy infrastructure company has delivered an impressive 69% return over the past year, with a current dividend yield of 4.3%.
These sales were conducted under a pre-established 10b5-1 trading plan, which Martin adopted on August 2, 2024. Following this transaction, Martin holds 843,652 shares directly. Additionally, he has an indirect interest in 277,950 shares held in a trust for family members, over which he shares voting and disposition power, although he disclaims beneficial ownership of these shares. According to InvestingPro, KMI currently trades at a P/E ratio of 22.7, suggesting a premium valuation relative to near-term earnings growth. InvestingPro subscribers have access to 10 additional key insights about KMI’s valuation and growth prospects.
The sales were executed in multiple transactions, with individual prices ranging from $27.575 to $27.855 per share. The stock has maintained consistent dividend payments for 15 consecutive years, reflecting strong financial stability.
In other recent news, Kinder Morgan Inc. outlined its 2025 business plan, projecting continued growth based on strong fundamentals. The company forecasts a growth in adjusted earnings per share (EPS) and adjusted EBITDA by 7% and 5% year-over-year, respectively, and anticipates generating $5.9 billion in cash flow from operations (CFFO) and $2.8 billion in free cash flow in 2025. Concurrently, ArcLight Capital Partners (WA:CPAP), LLC acquired a 25% equity interest in the Gulf Coast Express Pipeline LLC from an affiliate of Phillips 66 (NYSE:PSX), with Kinder Morgan’s subsidiary continuing to operate the pipeline.
In other developments, Kinder Morgan’s Board of Directors approved amendments to its bylaws aimed at streamlining corporate governance and shareholder engagement processes. Stifel analysts maintained their Hold rating on Kinder Morgan’s stock with a price target of $27.00, following the company’s fourth-quarter financial results for 2024 which fell slightly short of Stifel’s expectations. Meanwhile, Mizuho (NYSE:MFG) Securities reiterated its Outperform rating on Kinder Morgan with a steady price target of $33.00, despite the company’s adjusted EBITDA falling short of both Mizuho Securities USA and consensus estimates. These recent developments underline Kinder Morgan’s sustained growth and strong earnings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.